Global Orphan Drugs Market to Reach $545.4 Billion by 2027
Abstract: What`s New for 2022? Global competitiveness and key competitor percentage market shares. ...
Stay updated with breaking news from Treat Multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abstract: What`s New for 2022? Global competitiveness and key competitor percentage market shares. ...
(Pixabay) Thanks to COVID and virus research, a new mRNA ‘Vaccine Treatment’ for MS is in final development. The Multiple Sclerosis Society of Canada made the announcement in their January 25, 2021 Newsletter. They wrote: “BioNTech is Applying mRNA Vaccine Technology to Treat Multiple Sclerosis. BioNTech, a German biotechnology company that is working with Pfizer to develop a COVID-19 vaccine, reports that they are using the same technology to develop a therapeutic approach to multiple sclerosis (MS).” Jan. 25, 2021 Yahoo Finance Reports on BioNTech; “With the MS vaccine, the mRNA t...